World Liver Day 2026 highlights the theme “Solid Habits, Strong Liver,” emphasizing four essential lifestyle practices: eating a balanced diet, staying physically active, reducing alcohol intake, and undergoing regular liver check-ups. Together, these habits play a crucial role in maintaining liver health and preventing serious complications.
On this occasion, Bharat Serum and Vaccines Limited (BSV) reaffirmed its commitment to advancing continuous scientific education among healthcare practitioners, particularly in managing life-threatening bleeds associated with liver diseases.
Understanding the Liver’s Critical Role
The liver serves as the primary site for synthesizing most coagulation factors and plays a central role in maintaining hemostatic balance. However, excessive alcohol consumption continues to be one of the leading causes of liver damage worldwide, contributing to nearly half of all liver disease–related deaths.
Alcohol-related liver disease progresses through multiple stages. Initially, steatosis leads to fat accumulation in liver cells. Subsequently, the condition may advance to alcoholic hepatitis, which causes inflammation and presents with symptoms such as fatigue, jaundice, and abdominal discomfort. Eventually, cirrhosis develops, severely impairing liver function and leading to life-threatening complications.
Coagulopathy and Emerging Treatment Approaches
As liver disease advances, patients with cirrhosis or acute liver failure often experience a deficiency of procoagulant factors along with reduced anticoagulant proteins such as protein C, protein S, and antithrombin. Consequently, this imbalance disrupts normal hemostasis and may even trigger thrombosis.
Hepatic coagulopathy, therefore, remains a complex condition involving both bleeding and clotting risks. In such cases, one therapeutic option includes the use of 4-factor Prothrombin Complex Concentrate (4F-PCC), which enables rapid replacement of deficient clotting factors and helps manage severe bleeding episodes effectively.
Industry Perspective: Advancing Scientific Dialogue
Commenting on the initiative, Sivani Sarma Deka, COO – India Business at BSV, stated that the organization continues to drive scientific discussions among healthcare professionals through medical evidence, global expertise, and real-world data. Furthermore, she highlighted that BSV curates content-led sessions featuring globally recognized experts and leading medical institutions to share insights and practical experiences in bleed management.
She emphasized that building healthy habits remains fundamental to liver wellness and encouraged individuals to take proactive steps toward preventing complications.
Clinical Insights: Prevention Remains Key
Adding a clinical perspective, Dr. Gaurav Gupta, Liver Transplant and Hepato-Pancreato-Biliary Surgeon at Sir HN Reliance Foundation Hospital, explained that coagulopathy due to liver dysfunction is often complex and challenging to treat. In severe cases, patients may require large volumes of blood products, which can pose additional risks.
As per the press release, he noted that 4F-PCC offers an effective alternative for rapid correction of coagulopathy in life-threatening situations. However, he stressed that prevention remains the most effective strategy. With mindful lifestyle changes, the liver has a remarkable ability to repair and regenerate. Therefore, individuals—especially those with risk factors such as obesity, type 2 diabetes, alcohol use, family history of liver disease, or certain medications—should prioritize regular check-ups.
Driving Awareness for a Healthier Future
Observed annually on April 19, World Liver Day aims to raise awareness about liver health and related disorders. As the body’s metabolic powerhouse, the liver requires consistent care and attention.
Therefore, this day reinforces the importance of adopting healthy lifestyle behaviors while promoting regular screenings and timely interventions. Ultimately, such efforts can significantly reduce the burden of liver diseases and support long-term wellbeing.